Gateway Investment Advisers LLC Eli Lilly & CO Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 161,769 shares of LLY stock, worth $129 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

161,769

Previous 171,595 5.73%

Holding current value

$129 Million

Previous $155 Million 7.75%

% of portfolio

1.59%

Previous 1.77%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$772.14 - $960.02 $7.59 Million - $9.43 Million	-9,826 Reduced 5.73%	161,769 $143 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $1.4 Million - $1.75 Million	-1,927 Reduced 1.11%	171,595 $155 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $10.1 Million - $13.5 Million	-17,067 Reduced 8.95%	173,522 $135 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $4.89 Million - $5.76 Million	-9,303 Reduced 4.65%	190,589 $111 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $7.33 Million - $10.1 Million	-16,853 Reduced 7.78%	199,892 $107 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $284,450 - $380,342	-811 Reduced 0.37%	216,745 $102 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $5.32 Million - $6.24 Million	-17,116 Reduced 7.29%	217,556 $74.7 Million
Q4 2022 Jan 13, 2023	SELL	$321.55 - $374.67 $1.95 Million - $2.28 Million	-6,073 Reduced 2.52%	234,672 $0
Q3 2022 Oct 07, 2022	SELL	$296.48 - $337.87 $737,345 - $840,282	-2,487 Reduced 1.02%	240,745 $77.8 Million
Q2 2022 Jul 13, 2022	BUY	$278.73 - $327.27 $148,005 - $173,780	531 Added 0.22%	243,232 $78.9 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $384,891 - $478,322	1,640 Added 0.68%	242,701 $69.5 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $3.2 Million - $3.97 Million	-14,227 Reduced 5.57%	241,061 $66.6 Million
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $3.4 Million - $4.18 Million	-15,345 Reduced 5.67%	255,288 $59 Million
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $150,939 - $195,239	-836 Reduced 0.31%	270,633 $62.1 Million
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $2.33 Million - $3.02 Million	-14,210 Reduced 4.97%	271,469 $50.7 Million
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $9.27 Million - $12.3 Million	-71,040 Reduced 19.91%	285,679 $48.2 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $3.28 Million - $3.79 Million	-22,429 Reduced 5.92%	356,719 $52.8 Million
Q2 2020 Jul 15, 2020	SELL	$136.42 - $164.18 $5.04 Million - $6.07 Million	-36,977 Reduced 8.89%	379,148 $62.2 Million
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $2.81 Million - $3.48 Million	-23,598 Reduced 5.37%	416,125 $57.7 Million
Q4 2019 Jan 09, 2020	SELL	$106.92 - $132.43 $747,370 - $925,685	-6,990 Reduced 1.56%	439,723 $57.8 Million
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $4.66 Million - $5.07 Million	-43,624 Reduced 8.9%	446,713 $50 Million
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $2.52 Million - $2.94 Million	-22,724 Reduced 4.43%	490,337 $54.3 Million
Q1 2019 Apr 10, 2019	SELL	$111.31 - $131.02 $1.02 Million - $1.2 Million	-9,131 Reduced 1.75%	513,061 $66.6 Million
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $169,440 - $189,824	-1,600 Reduced 0.31%	522,192 $60.4 Million
Q3 2018 Oct 16, 2018	SELL	$85.86 - $107.31 $355,546 - $444,370	-4,141 Reduced 0.78%	523,792 $56.2 Million
Q2 2018 Jul 11, 2018	SELL	$75.7 - $86.88 $404,692 - $464,460	-5,346 Reduced 1.0%	527,933 $45 Million
Q1 2018 Apr 12, 2018	SELL	$74.21 - $87.6 $2.42 Million - $2.86 Million	-32,647 Reduced 5.77%	533,279 $41.3 Million
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $224,925 - $241,258	-2,745 Reduced 0.48%	565,926 $47.8 Million
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $43.8 Million - $48.6 Million	568,671	568,671 $48.6 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Eli Lilly & CO Transaction History